Legend Biotech (LEGN) Other Non Operating Income (2020 - 2026)

Legend Biotech (LEGN) has 6 years of Other Non Operating Income data on file, last reported at -$2.4 million in Q4 2025.

• Quarterly Other Non Operating Income fell 102.15% year-over-year to -$2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$55.0 million (down 149.15% YoY) and the FY2025 annual result came in at -$164.8 million, down 247.41% from the prior year.
• Other Non Operating Income fell to -$2.4 million in Q4 2025, from $354000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $111.4 million in Q4 2024 to a low of -$108.1 million in Q2 2025.
• A 5-year average of $3.6 million and a median of $7.2 million in 2021 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 47372.73% in 2021, down 3437.55% in 2021.
• Tracing LEGN's Other Non Operating Income over 5 years: stood at $31.2 million in 2021, then plunged by 129.81% to -$9.3 million in 2022, then soared by 208.07% to $10.1 million in 2023, then soared by 1008.43% to $111.4 million in 2024, then slumped by 102.15% to -$2.4 million in 2025.
• The last three Other Non Operating Income figures came in at -$2.4 million (Q4 2025), $354000.0 (Q3 2025), and -$108.1 million (Q2 2025), per Business Quant data.